MedTrace Logo

RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort

NCT02668510 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-09-25

No results posted yet for this study

Summary

A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy with Platelet Rich Plasma versus Extracorporeal Shock Wave Therapy in a High Demand Cohort with Resistant Plantar Fasciitis

Conditions

  • Fasciitis, Plantar

Interventions

BIOLOGICAL

platelet rich plasma

immediately following shockwave therapy the injection of PRP derived from subjects own blood using Arthex double syringe system will be injected at the origin of the plantar fascia at the calcaneous

DRUG

Normal saline

placebo injection of normal saline immediately following shockwave therapy

Sponsors & Collaborators

  • Edna Rath

    lead FED

Principal Investigators

  • Timothy B Pekari, DSc · WBAMC

  • Amanda L Allen, MD · WBAMC

  • Lola Norton · WBAMC

  • Desiree d diebold, md · wbamc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2023-12-11
Completion
2023-12-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02668510 on ClinicalTrials.gov